These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Scintigraphic detection of acute experimental myocardial infarct in dogs using 99m-2,3-dimercaptosuccinate]. Duska F; Kubícek J; Novák J; Kafka P; Vizda J; Mazurová Y Cas Lek Cesk; 1984 Dec; 123(52):1590-4. PubMed ID: 6097358 [No Abstract] [Full Text] [Related]
5. Differential renal function using technetium-99m dimercaptosuccinic acid (DMSA): in vitro correlation. Daly MJ; Jones W; Rudd TG; Tremann J J Nucl Med; 1979 Jan; 20(1):63-6. PubMed ID: 219166 [TBL] [Abstract][Full Text] [Related]
6. Tc-99m DMSA renal uptake: influence of biochemical and physiologic factors. Yee CA; Lee HB; Blaufox MD J Nucl Med; 1981 Dec; 22(12):1054-8. PubMed ID: 6273511 [TBL] [Abstract][Full Text] [Related]
7. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals. Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298 [TBL] [Abstract][Full Text] [Related]
8. Regional 99m technetium diphosphonate uptake in experimental dog heart infarct: relation to duration and severity of ischaemia. Peter T; Norris RM; Heng MK; Sammel NL Cardiovasc Res; 1979 Nov; 13(11):635-41. PubMed ID: 519666 [TBL] [Abstract][Full Text] [Related]
9. Effect of coronary blood flow and site of injection on Tc-99m PPi detection of early canine myocardial infarcts. Parkey RW; Kulkarni PV; Lewis SE; Datz FL; Dehmer GJ; Gutekunst DP; Buja LM; Bonte FJ; Willerson JT J Nucl Med; 1981 Feb; 22(2):133-7. PubMed ID: 7463157 [TBL] [Abstract][Full Text] [Related]
10. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model. Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299 [TBL] [Abstract][Full Text] [Related]
11. Optimal handling of dimercaptosuccinic acid for quantitative renal scanning. Taylor A; Lallone RL; Hagan PL J Nucl Med; 1980 Dec; 21(12):1190-3. PubMed ID: 6255114 [TBL] [Abstract][Full Text] [Related]
12. Technetium-99m(Sn2+)pyrophosphate in ischemic and infarcted dog myocardium in early stages of acute coronary occlusion: histochemical and tissue-counting comparisons. Bianco JA; Kemper AJ; Taylor A; Lazewatsky J; Tow DE; Khuri SF J Nucl Med; 1983 Jun; 24(6):485-91. PubMed ID: 6854398 [TBL] [Abstract][Full Text] [Related]
13. Renal handling of technetium-99m DMSA: further evidence for glomerular filtration and proximal tubular reabsorption. van Luijk WH; Piers DA; Beekhuis H; Meijer S J Nucl Med; 1986 Dec; 27(12):1943. PubMed ID: 3023565 [No Abstract] [Full Text] [Related]
14. A convenient method for the preparation of 99mTc(V)dimercaptosuccinic acid (99mTc(V)-DMSA). Westera G; Gadze A; Horst W Int J Appl Radiat Isot; 1985 Apr; 36(4):311-2. PubMed ID: 2991143 [TBL] [Abstract][Full Text] [Related]
15. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues. Buja LM; Tofe AJ; Kulkarni PV; Mukherjee A; Parkey RW; Francis MD; Bonte FJ; Willerson JT J Clin Invest; 1977 Sep; 60(3):724-40. PubMed ID: 893676 [TBL] [Abstract][Full Text] [Related]
16. [The pathophysiologic basis for the incorporation of 99mTc-pyrophosphate into myocardial infarct]. Duska F; Hadas L; Volenec K; Palicka V; Mazurová Y; Vizd'a J; Kafka P; Urbanová E; Kuba M; Veverková O Cesk Radiol; 1989 Aug; 43(4):241-9. PubMed ID: 2551518 [TBL] [Abstract][Full Text] [Related]